Figures computed from official regulatory filings — .
Ownershipinsiders 0% · institutions 91.03%
In EUR · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for EUROBIO-SCIENTIFIC only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Eurobio Scientific Société anonyme engages in research, development, and marketing specialty diagnostic products in the areas of transplantation, infectious diseases, autoimmunity, oncology, and life sciences. The company produces and markets transport and preservation media for corneal grafts; AlloMap, for heart transplant follow up; cell culture media, molecular biology reagents, contract manufacturing service, and proprietary antibodies; TQS (Tetanus Quick Stick), a rapid test used in emergency departments or pharmacies to assess the vaccination status or immune protection of patients against tetanus; EBX molecular biology ranges in the field of infectious diseases; and EndoPredict range, a second-generation multigene expression test for postmenopausal women with early-stage breast cancer, ER positive, and HER2 negative, as well as Prolaris. It also provides GenDx, EurobioPlex, FungiLine, Biosafety PKA, and immunology products. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Market information source · Oct 19, 2026
Open-market timeline · full history
12 buys23 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| EurobioNext | Other | $93.4M | AMF |
| Cathie MARSAIS | Buy | $79.3K | conv 61ClusterFirst in 12mo | AMF |
| Michel Picot | Buy | $92.4K | conv 55ClusterFirst in 12mo | AMF |
| Hervé Duchesne de Lamotte | Buy | $97.3K | conv 65ClusterFirst in 12mo | AMF |
| Denis FORTIERtrack record | Buy | $154.7K | conv 72ClusterUnusual size | AMF |
| Denis FORTIERtrack record | Buy | $33.1K | conv 70First in 12mo | AMF |
| Denis FORTIERtrack record | Buy | $1.6K | conv 35 | AMF |
| Denis FORTIERtrack record | Buy | $16.4 | conv 54 | AMF |
| Denis FORTIERtrack record | Buy | $16.5K | conv 54 | AMF |
| Denis FORTIERtrack record | Buy | $16.6K | conv 81First in 12mo | AMF |
| Denis FORTIERtrack record | Buy | $27K | conv 55 | AMF |
| EurobioNext | Buy | $5M | conv 58First in 12mo | AMF |
| Denis FORTIERtrack record | Other | $25M | AMF |
| Denis FORTIERtrack record | Sell | $11.6M | Unusual size | AMF |
| Cécile Fortier | Sell | $523.7K | AMF |
| Catherine Duchesne de Lamotte | Sell | $105.9K | AMF |
| Lucie Fortier | Sell | $1.4M | AMF |
| Margaux Fortier | Sell | $1.4M | AMF |
| Jean-Michel CARLE GRANDMOUGIN | Sell | $16.3M | Unusual size | AMF |
| Jean-Michel CARLE GRANDMOUGIN | Other | $23.2M | AMF |
| EurobioNext Société par actions simplifiés | Other | $48.3M | AMF |
| EurobioNext Société par actions simplifiés | Buy | $36.7M | conv 55First in 12mo | AMF |
| Hervé Duchesne de Lamotte | Sell | $306K | Unusual size | AMF |
| Denis FORTIERtrack record | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |
| Lucie Fortier | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | AMF |